November 12, 2007 - Beyond hospital visits and varied medical treatments lies a new groundbreaking report confirming the benefit of addressing cancer patients' emotional and psychological needs.

The Institute of Medicine (IOM) recently released a study, Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs, which reinforces Gilda's Club Worldwide's program philosophy that social and emotional support are integral to medical treatment when cancer is in the family.

Through report findings, the IOM issues a call to action among medical professionals to increase the standard of psychosocial care for all cancer patients.

The study stated, "It has been shown that both cancer patients and their families are at increased risk for anxiety and depression related to the strain of the disease. These mental states can cause harmful health effects of their own, compounding the challenges of treatment."

Since opening its first red door in 1995, and well ahead of the IOM findings, Gilda's Club has developed program elements that researchers have now found help to improve the quality of survival.

Gilda's Club offers an environment to share information and coping strategies through a variety of activities from yoga, tai chi, nutrition and cooking classes to networking and educational workshops and lectures, each reflecting the interests and needs of the local membership.

Additional findings of the IOM study confirm, "All components of the health care system that are involved in cancer care should explicitly incorporate attention to psychosocial needs into their policies, practices, and standards addressing clinical health care."

For more information: www.gildasclub.org and www.nap.edu


Related Content

News | Artificial Intelligence

September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a ...

Time September 07, 2023
arrow
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
arrow
News | Interventional Radiology

Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions.

Time July 03, 2019
arrow
Technology | Focused Ultrasound Therapy

Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of Exablate Neuro to include the treatment of patients with tremor-dominant Parkinson's disease (PD).

Time December 21, 2018
arrow
Videos | Radiation Oncology

Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation ...

Time November 06, 2018
arrow
News | Radiation Dose Management

AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes.

Time September 24, 2018
arrow
News | Radiation Oncology

World Cancer Day takes place annually on Feb. 4 to raise awareness and education in the media, governments and people ...

Time February 01, 2018
arrow
News | Oncology Related Products

December 19, 2016 — Children’s National Health System and Celsion Corp. announced in November the launch of a clinical ...

Time December 19, 2016
arrow
News | Clinical Decision Support

October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use ...

Time October 27, 2016
arrow
News | Ultrasound Imaging

September 12, 2016 — Tiny microbubbles are being used to more effectively identify liver tumors, according to a study ...

Time September 12, 2016
arrow
Subscribe Now